A number of FKBP12 ligands were designed and synthesised and their aff
inity for FKBP12 assessed. In these ligands the pyranose ring of FK506
was replaced by other mole synthetically accessible groups. The prepa
ration of suitable intermediates for the synthesis of ''dual domain''
inhibitors (compounds 6a-c, 15 and 22) is also described.